HMSM Members

Morphine is frequently used in the management of chronic pain when other analgesic options fail to provide sufficient relief. Chronic pain may arise from conditions such as advanced cancer, severe arthritis, neuropathic disorders, or long-term musculoskeletal injury. In these cases, the goal of therapy is not only pain reduction but also improvement in functional ability and overall quality of life.

Unlike acute pain, chronic pain requires long-term treatment planning. Morphine is typically introduced after non-opioid analgesics and weaker opioids have proven inadequate. Clinicians carefully evaluate the nature of the pain, its intensity, and its impact on daily living before initiating therapy. A thorough patient history is essential to assess potential risks, including respiratory conditions or previous opioid exposure.

Long-acting or controlled-release formulations of morphine are commonly used for chronic pain. These formulations provide steady plasma concentrations, minimizing fluctuations in pain control and reducing the need for frequent dosing. Immediate-release morphine may still be used for breakthrough pain episodes.

Tolerance is a known challenge in long-term morphine therapy. Over time, patients may require dose adjustments to maintain analgesic effectiveness. This process must be handled cautiously to avoid unnecessary dose escalation and increased side-effect risk. Regular reassessment ensures that morphine continues to provide meaningful benefit.

Side effects such as constipation, drowsiness, and nausea are common during chronic therapy and often require proactive management. Constipation, in particular, rarely resolves without intervention and typically necessitates routine bowel regimens.